Effects of Proprioceptive Neuromuscular Training on Sensory & Motor

Status Completed

Clinical Trial Summary

This study aims to determine the effects of Proprioceptive Neuromuscular Training on Sensory versus Motor Function in patients presenting with Guillain Barre Syndrome.

Clinical Trial Description

This study will be a randomized controlled trial and will be conducted to determine the effects of proprioceptive neuro-muscular training on sensory and motor function of lower limb,In this study data will be collected from multiple Hospitals of Lahore via Berg Balance Scale, Timed Up and Go test One Leg Stance test before and after intervention. Non- probability convenient sampling technique will be used to enroll 26 patients in total. The patients will be randomly allocated into two groups through lottery method, to either the proprioceptive training group or control group.Both groups will be assessed for proprioception via lower extremity position test as a baseline. Proprioception training programme will be implemented in experimental group and will be carried out for eight weeks, with three (60-minute) sessions per week. It will start with 10 minutes of Warm-up. This will be followed by 30 minutes of proprioceptive exercises targeting lower extremities. Proprioceptive exercises will be divided into three components, standing on Foam with eyes open and eyes closed and passing any object from one subject to the other for 10 minutes, throwing and catching a ball will be performed while standing on foam for additional 10 minutes, throwing and catching a ball, will be performed on trampoline to further challenge the balance system. After each set of 10-minute exercise, the subjects will be given two-minute resting periods. In the end, 10 minutes will be given for cool down exercises to bring the heart rate back to resting level. All participants in both groups will be evaluated before and after the treatment programs. Data will be analyzed by using Statistical Package of Social Sciences Version 26. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05491096
Study type	Interventional
Source	Riphah International University
Contact
Status	Completed
Phase	N/A
Start date	June 5, 2022
Completion date	February 28, 2023

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04053452` - Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome	N/A
Recruiting	`NCT02582853` - sCD163 as a Potential Biomarker in Guillain- Barré Syndrome	N/A
Completed	`NCT00056810` - Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine	Phase 2
Completed	`NCT05104762` - IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients	Phase 2/Phase 3
Recruiting	`NCT05630313` - Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil
Recruiting	`NCT03801135` - Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation	N/A
Active, not recruiting	`NCT01655394` - Change of Nerve Conduction Properties in IVIg Dependent Neuropathies	N/A
Completed	`NCT04927598` - Predictors and Prognostic Factors of Gullian Barrie Syndrome Outcome
Completed	`NCT06334796` - Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology	Early Phase 1
Not yet recruiting	`NCT04092140` - Neuromuscular Ultrasound in Correlation to Neurophysiological Findings
Not yet recruiting	`NCT04550611` - Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome	N/A
Withdrawn	`NCT03268304` - Feasibility of Two New Software Modules for the Rehabilitation of Patients With Neuromuscular Upper Limb Impairments
Not yet recruiting	`NCT05701189` - Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome	Phase 2
Withdrawn	`NCT02459808` - Gastrointestinal Transit Time in Patients With Guillain-Barré Syndrome	N/A
Completed	`NCT04752566` - A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome	Phase 3
Completed	`NCT05292690` - An Assistive Powered Wheelchair: Stage 2 Trial
Not yet recruiting	`NCT06300359` - Prognostic Indicators of Gullian-Barre Syndrome
Completed	`NCT00575653` - Safety Study of GBS Following Menactra Meningococcal Vaccination	N/A
Not yet recruiting	`NCT05114941` - Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome	N/A
Completed	`NCT05945784` - Exploring Accessible Beauty for Individuals With Upper Extremity Deficits

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of Proprioceptive Neuromuscular Training on Sensory and Motor Function in Guillain Barre Syndrome

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms